SOPHiA DDM™ for Hereditary Cancers  Enables Krsnaa Diagnostics to Expand its NGS Offerings BOSTON and LAUSANNE, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Krsnaa Diagnostics, India’s largest diagnostic services provider in radiology and pathology, is live on SOPHiA DDM™ technology. […]

SAN DIEGO, CA – Todaro Robotics, Inc, a leading laboratory automation and robotics company based in San Diego, has achieved a major milestone with its flagship client Abwiz Bio, Inc a company that speeds up the development of high impact monoclonal antibodies with its proprietary phage display technology.The milestone of operating continuously a very complex […]

MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced it that it has reached a significant milestone with more than 1,000 Ella™ automated immunoassay instruments now in the field. The achievement is a testament to the growing demand across scientific and clinical research sectors for a fast and efficient immunoassay solution capable of delivering precise, and reliable biomarker analysis. Manufactured under […]

OPHiA DDM™ HRD Solution will help empower clinical researchers to advance cancer research   BOSTON and LAUSANNE, Switzerland  SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Tel Aviv Sourasky Medical Center (Ichilov), the largest acute care facility in Israel, has chosen to use […]

SAN DIEGO — Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced it has already exceeded more than 200 orders for its revolutionary NovaSeq X sequencing system in the first quarter of 2023. The orders represent a diverse customer base spanning research and clinical customer segments in nearly 30 […]

HUNTSVILLE, Ala. —Discovery Life Sciences™ (Discovery), the Biospecimen and Biomarker Specialists™, has announced that Discovery Genomics is the first commercial service laboratory in the world to receive two of the new NovaSeqTM X Plus Sequencing Systems from Illumina, Inc.  Discovery Genomics will expand its platform to five systems by the end of the year―positioning itself as […]

SOUTH PLAINFIELD, NEW JERSEY, USA — Admera Health, a leading provider of Next-Generation Sequencing services for researchers worldwide, has announced the acquisition of an Illumina NovaSeq X Plus sequencer to bolster its offering. The NovaSeq X Plus is a cutting-edge technology that enables high-throughput sequencing and supports a wide range of applications, including whole genome sequencing, transcriptome sequencing, targeted sequencing, […]

UPPSALA, Sweden — Olink Holding AB (publ) (Nasdaq: OLK) today announced that the regional proteomic facility, D-CYPHR in Cape Town, South Africa has adopted Olink technology and has become the first service provider using the Olink® Target and Olink® Flex platforms for targeted protein biomarker discovery on the African continent. D-CYPHR is a new facility co-founded by […]

NORTH AUGUSTA, S.C. and DEVENS, Mass. — AmbioPharm, a worldwide leader in peptide API CDMO services, announces the acquisition of new, disruptive, peptide purification technology developed by YMC which leverages several of YMC’s patented1 twin-column purification processes. Twin-column chromatography or Multicolumn Countercurrent Solvent Gradient Purification (MCSGP) is a continuous chromatographic process which collects a high purity center cut fraction and internally recycles mixed […]

The New Assay Will Screen Patients for Clinical Trials and Help Increase Data Analysis for Clinical Researchers BOSTON & LAUSANNE, Switzerland — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Acutis Diagnostics, a specialized medical laboratory, will use SOPHiA DDM™ to develop […]